Which physical findings are characteristic of chronic vitamin A toxicity?

Answer

Chronic vitamin A toxicity affects the skin, the mucous membranes, and the musculoskeletal and neurologic systems. Skin and mucous membrane effects include erythema, eczema, pruritus, dry and cracked skin, angular cheilitis, conjunctivitis, palmar and plantar peeling, and alopecia.

Musculoskeletal effects include pain and tenderness, particularly in the long bones of the upper and lower extremities, which may be exacerbated by exercise. Neurologic effects include blurred vision and frontal headache, which is often the first sign of toxicity.

In addition, studies suggest that elevated levels of vitamin A may cause increased bone resorption and promote the development of osteoporosis.^{[5, 44]}

Manifestations of chronic vitamin A toxicity also include the following:

Alopecia
Erythematous dermatitis
Skin desquamation
Brittle nails
Exanthema
Cheilitis
Conjunctivitis
Petechiae
Liver cirrhosis
Hepatosplenomegaly
Peripheral neuritis
Benign intracranial hypertension
Ataxia
Papilledema
Diplopia
Hyperostosis
Edema
Hepatic hydrothorax^[45]
Hepatomegaly
Ascites
Migratory arthritis
Craniotabes (in children)
Bulging fontanelle (in infants)
Epiphyseal capping and premature epiphyseal closure

Did this answer your question?

Yes No

Additional feedback? (Optional)

Thank you for your feedback!

Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019 Dec. 57 (12):1220-1413. [Medline]. [Full Text].
American Association of Poison Control Centers’ National Poison Data System. Annual Reports. Available at http://www.aapcc.org/annual-reports. Accessed: May 30, 2020.
North America, Asia lead vitamin and supplement usage. Nielsen Wire. Available at https://www.nielsen.com/us/en/insights/article/2009/north-america-asia-lead-vitamin-and-supplement-usage/#:~:text=According%20to%20a%20new%20Nielsen,and%2043%25%2C%20respectively).. March 13, 2009; Accessed: May 30, 2020.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Multivitamin/mineral Supplements. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/MVMS-HealthProfessional/. July 8, 2015; Accessed: May 30, 2020.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin A. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/vitamina.asp. June 05, 2013; Accessed: May 30, 2020.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin B6. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/. September 15, 2011; Accessed: May 30, 2020.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin B12. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/. June 24, 2011; Accessed: May 30, 2020.
Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, et al. Intravenous Vitamin C and Cancer: A Systematic Review. Integr Cancer Ther. 2014 May 26. 13(4):280-300. [Medline].
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin C. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/. June 05, 2013; Accessed: May 30, 2020.
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin D. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/. November 10, 2014; Accessed: May 30, 2020.
Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005 Jan 4. 142(1):37-46. [Medline]. [Full Text].
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012 Mar 14. 3:CD007176. [Medline].
Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin E. National Institutes of Health. Available at http://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/. Accessed: October 13, 2014.
Office of Dietary Supplements. Nutrient Recommendations: Dietary Reference Intakes (DRI). NIH.GOV. Available at https://ods.od.nih.gov/Health_Information/Dietary_Reference_Intakes.aspx. Accessed: May 30, 2020.
Tan KP, Kosuge K, Yang M, Ito S. NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity. Free Radic Biol Med. 2008 Dec 15. 45(12):1663-73. [Medline].
Maqbool A, Stallings VA. Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med. 2008 Nov. 14(6):574-81. [Medline].
Mawson AR. On the association between low resting heart rate and chronic aggression: retinoid toxicity hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17. 33(2):205-13. [Medline].
Lee YH, Scharnitz TP, Muscat J, Chen A, Gupta-Elera G, Kirby JS. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis. JAMA Dermatol. 2016 Jan. 152 (1):35-44. [Medline].
Corrigan JJ Jr, Marcus FI. Coagulopathy associated with vitamin E ingestion. JAMA. 1974 Dec 2. 230(9):1300-1. [Medline].
Diplock AT. Safety of antioxidant vitamins and beta-carotene. Am J Clin Nutr. 1995 Dec. 62(6 Suppl):1510S-1516S. [Medline]. [Full Text].
Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001 Nov 29. 345(22):1583-92. [Medline]. [Full Text].
Cheung MC, Zhao XQ, Chait A, Albers JJ, Brown BG. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol. 2001 Aug. 21(8):1320-6. [Medline]. [Full Text].
Liu M, Wallin R, Wallmon A, Saldeen T. Mixed tocopherols have a stronger inhibitory effect on lipid peroxidation than alpha-tocopherol alone. J Cardiovasc Pharmacol. 2002 May. 39(5):714-21. [Medline].
Hathcock JN, Azzi A, Blumberg J, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr. Apr 2005. 81(4):736-45.
Debreceni B, Debreceni L. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?. Cardiovasc Ther. 2012 Aug. 30(4):227-33. [Medline].
Harling L, Rasoli S, Vecht JA, Ashrafian H, Kourliouros A, Athanasiou T. Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials. Heart. 2011 Oct. 97(20):1636-42. [Medline].
Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003 Jun 14. 361(9374):2017-23. [Medline].
Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med. 2007 Aug 13-27. 167(15):1610-8. [Medline]. [Full Text].
Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12. 306(14):1549-56. [Medline].
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6. 360(9326):23-33. [Medline].
Shekelle PG, Morton SC, Jungvig LK, Udani J, Spar M, Tu W, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med. 2004 Apr. 19(4):380-9. [Medline]. [Full Text].
Orrell RW, Lane RJ, Ross M. A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Amyotroph Lateral Scler. 2008 Aug. 9(4):195-211. [Medline].
Lane JS, Magno CP, Lane KT, Chan T, Hoyt DB, Greenfield S. Nutrition impacts the prevalence of peripheral arterial disease in the United States. J Vasc Surg. 2008 Oct. 48(4):897-904. [Medline].
Mahabir S, Schendel K, Dong YQ, Barrera SL, Spitz MR, Forman MR. Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. Int J Cancer. 2008 Sep 1. 123(5):1173-80. [Medline]. [Full Text].
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005 Mar 16. 293(11):1338-47. [Medline]. [Full Text].
Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004 Jul 26. 164(14):1552-6. [Medline].
Liede KE, Haukka JK, Saxén LM, Heinonen OP. Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid. Ann Med. 1998 Dec. 30(6):542-6. [Medline].
Leppälä JM, Virtamo J, Fogelholm R, Huttunen JK, Albanes D, Taylor PR, et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol. 2000 Jan. 20(1):230-5. [Medline]. [Full Text].
Handelman GJ. High-dose vitamin supplements for cigarette smokers: caution is indicated. Nutr Rev. 1997 Oct. 55(10):369-70. [Medline].
Spiller HA, Good TF, Spiller NE, Aleguas A. Vitamin D exposures reported to US poison centers 2000-2014: Temporal trends and outcomes. Hum Exp Toxicol. 2015 Oct 30. [Medline].
Genaro Pde S, Martini LA. Vitamin A supplementation and risk of skeletal fracture. Nutr Rev. 2004 Feb. 62(2):65-7. [Medline].
Bhalla K, Ennis DM, Ennis ED. Hypercalcemia caused by iatrogenic hypervitaminosis A. J Am Diet Assoc. 2005 Jan. 105(1):119-21. [Medline].
Bilbao NA. Vitamin D Toxicity in Young Breastfed Infants: Report of 2 Cases. Glob Pediatr Health. 2017. 4:2333794X17731695. [Medline]. [Full Text].
Ribaya-Mercado JD, Blumberg JB. Vitamin A: is it a risk factor for osteoporosis and bone fracture?. Nutr Rev. 2007 Oct. 65(10):425-38. [Medline].
Miksad R, de Lédinghen V, McDougall C, Fiel I, Rosenberg H. Hepatic hydrothorax associated with vitamin a toxicity. J Clin Gastroenterol. 2002 Mar. 34(3):275-9. [Medline].
Barker ME, Blumsohn A. Is vitamin A consumption a risk factor for osteoporotic fracture?. Proc Nutr Soc. 2003 Nov. 62(4):845-50. [Medline].
Johnson-Davis KL, Moore SJ, Owen WE, Cutler JM, Frank EL. A rapid HPLC method used to establish pediatric reference intervals for vitamins A and E. Clin Chim Acta. 2009 Jul. 405(1-2):35-8. [Medline].

Media Gallery

of 0

Author

Mark Rosenbloom, MD, MBA Chief Executive Officer and Editorial Director, PEPID, LLC; Founder and Chairman, The Unicorn Children's Foundation; Chief Medical Officer, LIFEFORCE Medical Institute

Mark Rosenbloom, MD, MBA is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, Royal Society of Medicine, American Academy of Anti-Aging Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Angela Gentili, MD Director of Geriatric Medicine Fellowship Program, Professor of Internal Medicine, Division of Geriatric Medicine, Virginia Commonwealth University Health System and McGuire Veterans Affairs Medical Center, Richmond, VA

Angela Gentili, MD is a member of the following medical societies: Virginia Geriatrics Society, American Geriatrics Society

Disclosure: Nothing to disclose.

Chief Editor

Michael A Miller, MD Clinical Professor of Emergency Medicine, Medical Toxicologist, Department of Emergency Medicine, Texas A&M Health Sciences Center; CHRISTUS Spohn Emergency Medicine Residency Program

Michael A Miller, MD is a member of the following medical societies: American College of Medical Toxicology

Disclosure: Nothing to disclose.

Acknowledgements

Robert A Adler, MD Chief of Endocrinology and Metabolism, McGuire Veterans Affairs Medical Center; Professor, Departments of Internal Medicine and Epidemiology and Community Health, Virginia Commonwealth University

Robert A Adler, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Federation for Medical Research, American Society for Bone and Mineral Research, and Endocrine Society

Disclosure: Eli Lilly Grant/research funds Independent contractor; Genentech Grant/research funds Independent contractor

Mohsen S Eledrisi, MD, FACP, FACE Consultant, Department of Internal Medicine, Division of Endocrinology and Metabolism, King Abdulaziz National Guard Medical Center, Saudi Arabia

Mohsen S Eledrisi, MD, FACP, FACE is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Physicians-American Society of Internal Medicine, American Diabetes Association, American Medical Association, and Endocrine Society